| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/04/2003 | CA2477234A1 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 09/04/2003 | CA2477225A1 Novel compositions and methods for cancer |
| 09/04/2003 | CA2477171A1 Nanostructures containing pna joining or functional elements |
| 09/04/2003 | CA2477170A1 Compositions and methods for eliciting an immune response to gram-negative bacterial infections |
| 09/04/2003 | CA2477039A1 Methods of producing phosphitylated compounds |
| 09/04/2003 | CA2477037A1 Recombinant negative strand virus rna expression systems and vaccines |
| 09/04/2003 | CA2477002A1 Assays to monitor amyloid precursor protein processing |
| 09/04/2003 | CA2476890A1 Subtilisin carlsberg proteins with reduced immunogenicity |
| 09/04/2003 | CA2476887A1 Gasp1:a follistatin domain containing protein |
| 09/04/2003 | CA2476846A1 Method for detection of leptin receptor ligands |
| 09/04/2003 | CA2476776A1 Reagents and treatment methods for autoimmune diseases |
| 09/04/2003 | CA2476769A1 Carbohydrate-modified polymers, compositions and uses related thereto |
| 09/04/2003 | CA2476666A1 Haemophilus adherence and penetration proteins |
| 09/04/2003 | CA2476654A1 Follistatin domain containing proteins |
| 09/04/2003 | CA2476518A1 Compositions and methods for the treatment of immune related diseases |
| 09/04/2003 | CA2476481A1 Recombinase polymerase amplification |
| 09/04/2003 | CA2476480A1 Methods of making hypermutable cells using pmsr homologs |
| 09/04/2003 | CA2476041A1 Delta 6-desaturases from primulaceae, expressing plants and pufa-containing oils |
| 09/04/2003 | CA2475547A1 Method for the recombination of genetic elements |
| 09/04/2003 | CA2475526A1 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours |
| 09/04/2003 | CA2475509A1 Treatment methods using anti-cd22 antibodies |
| 09/04/2003 | CA2475433A1 Trpm-2 antisense therapy using an oligonucleotide having 2'-o-(2-methoxyl)ethyl modifications |
| 09/04/2003 | CA2472554A1 Methods of using fet labeled oligonucleotides that include a 3' 5' exonuclease resistant quencher domain and compositions for practicing the same |
| 09/04/2003 | CA2471307A1 Protein complexes and methods for their use |
| 09/04/2003 | CA2467836A1 Interfacial biomaterials |
| 09/04/2003 | CA2459155A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 09/04/2003 | CA2451982A1 Method and nucleic acids for the analysis of colorectal cell proliferative disorders |
| 09/04/2003 | CA2430580A1 Specialized dual condensation/epimerization domain in non-ribosomal peptide synthetase systems |
| 09/03/2003 | EP1340979A2 Neuropeptide receptor and uses thereof |
| 09/03/2003 | EP1340821A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction |
| 09/03/2003 | EP1340820A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction |
| 09/03/2003 | EP1340819A1 Microsatellite markers |
| 09/03/2003 | EP1340818A1 Method and nucleic acids for the analysis of a colon cell proliferative disorder |
| 09/03/2003 | EP1340815A2 Determination of alpha-N-acetylgalactosaminidase activity |
| 09/03/2003 | EP1340814A1 Thermostable xylanases |
| 09/03/2003 | EP1340813A1 Process for producing viral rna polymerase |
| 09/03/2003 | EP1340812A2 Functional domains in flavobacterium okeanokoites (Foki) restriction endonuclease |
| 09/03/2003 | EP1340811A2 Antibodies with specificity for multiple adhesion molecules |
| 09/03/2003 | EP1340769A1 CD4-gamma2 and CD4-IgG2 chimeras |
| 09/03/2003 | EP1340765A2 Inverted chimeric and hybrid oligonucleotides |
| 09/03/2003 | EP1340764A2 Nucleic acid mediated electron transfer |
| 09/03/2003 | EP1340544A1 Biochip including carbon nanotubes and method for sample separation using the same |
| 09/03/2003 | EP1340505A2 Therapeutic use of cis-element decoys in vivo |
| 09/03/2003 | EP1340424A1 Double transgenic animal model for Alzheimer's disease |
| 09/03/2003 | EP1340184A2 Method and system for modeling biological systems |
| 09/03/2003 | EP1340088A2 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
| 09/03/2003 | EP1339879A2 Method of identifying a polymorphism in cyp2d6 |
| 09/03/2003 | EP1339878A2 Method for identifying modulators of transcription |
| 09/03/2003 | EP1339877A1 Isothermal amplification of nucleic acids on a solid support |
| 09/03/2003 | EP1339875A2 Compositions and methods for rapidly generating recombinant nucleic acid molecules |
| 09/03/2003 | EP1339874A2 Method for generating a library of mutant oligonucleotides using the linear cyclic amplification reaction |
| 09/03/2003 | EP1339872A2 Genetic markers for tumors |
| 09/03/2003 | EP1339870A2 Methods for external controls for nucleic acid amplification |
| 09/03/2003 | EP1339869A2 Obesity associated biallelic marker maps |
| 09/03/2003 | EP1339868A2 Methods for isolating centromere dna |
| 09/03/2003 | EP1339867A2 ALTERATIONS IN THE LONG QT SYNDROME GENES i KVLQT1 /i AND i SCN5A /i AND METHODS FOR DETECTING SAME |
| 09/03/2003 | EP1339866A2 Human testis specific serine/threonine kinase |
| 09/03/2003 | EP1339863A2 Double transposition methods for manipulating nucleic acids |
| 09/03/2003 | EP1339862A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 09/03/2003 | EP1339861A2 Inducible highly productive raav packaging cell-lines |
| 09/03/2003 | EP1339860A2 Novel targets for herbicides and transgenic plants resistant to said herbicides |
| 09/03/2003 | EP1339859A2 Processes and vectors for producing transgenic plants |
| 09/03/2003 | EP1339858A2 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence programmed and cell death in plants |
| 09/03/2003 | EP1339857A2 Enhancement of freezing tolerance in transgenic plants |
| 09/03/2003 | EP1339856A1 Production of heterologous polypeptides in yeast |
| 09/03/2003 | EP1339855A2 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems |
| 09/03/2003 | EP1339854A2 Lipid metabolism enzymes |
| 09/03/2003 | EP1339853A1 Isolated luciferases and the use thereof |
| 09/03/2003 | EP1339852A2 Methods and materials for the synthesis of organic products |
| 09/03/2003 | EP1339851A2 Basb221 polypeptides and polynucleotides encoding basb221 polypeptides |
| 09/03/2003 | EP1339850A2 A novel cocoa albumin and its use in the production of cocoa and chocolate flavour |
| 09/03/2003 | EP1339849A2 PLANT POLYNUCLEOTIDES ENCODING NOVEL Na+ /H+ ANTIPORTERS |
| 09/03/2003 | EP1339848A2 A novel protein selectively expressed in osteoblasts |
| 09/03/2003 | EP1339847A2 Transforming growth factor-beta-related molecules and uses thereof |
| 09/03/2003 | EP1339846A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/03/2003 | EP1339845A2 Adipocyte complemented related protein zacrp3x2 |
| 09/03/2003 | EP1339844A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/03/2003 | EP1339843A2 Human transporter proteins nucleic acid molecules encoding them and uses thereof |
| 09/03/2003 | EP1339842A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/03/2003 | EP1339841A2 Identification of neuroblastoma tumor suppressor genes |
| 09/03/2003 | EP1339840A2 Schizophrenia-related voltage-gated ion channel gene and protein |
| 09/03/2003 | EP1339838A2 Multiple array system for integrating bioarrays |
| 09/03/2003 | EP1339837A2 Prolyl endoprotease from aspergillus niger |
| 09/03/2003 | EP1339836A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 09/03/2003 | EP1339834A2 Enzymes |
| 09/03/2003 | EP1339828A2 Yeast-based assays involving gpcrs |
| 09/03/2003 | EP1339798A2 Sulfonated diarylrhodamine dyes |
| 09/03/2003 | EP1339750A2 Process for selecting anti-angiogenesis antibody fragments, anti-angiogenesis antibody fragments thus obtained and their use |
| 09/03/2003 | EP1339748A2 G-protein coupled receptors |
| 09/03/2003 | EP1339747A2 Membrane fusion proteins derived from reovirus |
| 09/03/2003 | EP1339746A2 Binding polypeptides for b lymphocyte stimulator protein (blys) |
| 09/03/2003 | EP1339745A1 Immunotherapeutic methods and molecules |
| 09/03/2003 | EP1339744A2 Production of recombinant bmp-2 |
| 09/03/2003 | EP1339742A2 Human protein differentially expressed in alzheimer's disease's brain |
| 09/03/2003 | EP1339740A2 Methods and cells for detecting modulators of rgs proteins |
| 09/03/2003 | EP1339738A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 09/03/2003 | EP1339737A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 09/03/2003 | EP1339736A2 Oncolytic virus |
| 09/03/2003 | EP1339732A1 Specific double-stranded probes for homogeneous detection of nucleic acid and their application methods |
| 09/03/2003 | EP1339427A2 Method of producing biospecific molecules by protein trans-splicing |